2003
DOI: 10.1007/s15010-002-3083-0
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of Tropheryma whipplei DNA in Patients with Various Gastrointestinal Diseases and in Healthy Controls

Abstract: We conclude that the asymptomatic carrier state of T. whipplei indeed exists and that it is much more frequent than the rare Whipple's disease. The higher prevalence of T. whipplei DNA in the saliva of patients with reflux syndrome suggests that the stomach might be the habitat of the organism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
40
0

Year Published

2004
2004
2024
2024

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 61 publications
(40 citation statements)
references
References 24 publications
0
40
0
Order By: Relevance
“…Microscopy of biopsy samples is a costly and invasive method and therefore not frequently used for screening purposes and usually performed only to confirm the diagnosis in the case of a serious suspicion of infection. Carriage of T. whipplei was first suggested by Dutly and Altwegg (37), and since then T. whipplei DNA has been detected in stool, saliva, and biopsy samples from asymptomatic individuals by using PCR (18,(41)(42)(43)(44)(45). Upon the initial encounter with T. whipplei, most carriers develop a protective immune response that prevents further spread of the bacterium through the body or eliminates the bacterium completely (46)(47)(48).…”
Section: Carriage Of Tropheryma Whippleimentioning
confidence: 99%
See 2 more Smart Citations
“…Microscopy of biopsy samples is a costly and invasive method and therefore not frequently used for screening purposes and usually performed only to confirm the diagnosis in the case of a serious suspicion of infection. Carriage of T. whipplei was first suggested by Dutly and Altwegg (37), and since then T. whipplei DNA has been detected in stool, saliva, and biopsy samples from asymptomatic individuals by using PCR (18,(41)(42)(43)(44)(45). Upon the initial encounter with T. whipplei, most carriers develop a protective immune response that prevents further spread of the bacterium through the body or eliminates the bacterium completely (46)(47)(48).…”
Section: Carriage Of Tropheryma Whippleimentioning
confidence: 99%
“…Asymptomatic carriers of T. whipplei represent a large reservoir from which other humans might be colonized. The bacterium has been found in various samples, including saliva, urine, blood, cardiac valve, myocardium, synovial fluid, skeletal muscle, stool, skin, lymph node, lung, bronchoalveolar fluid, stomach, spleen, liver, larynx, small bowel, colon, maxillary sinus, cerebrospinal fluid, brain, and aqueous humor samples (18,42,43,45,(49)(50)(51).…”
Section: Carriage Of Tropheryma Whippleimentioning
confidence: 99%
See 1 more Smart Citation
“…However, it is now known that the disease is often multisystemic, including possible cardiac and central nervous system involvement, and has clinical manifestations that may be varied and nonspecific (Table 1). T. whipplei has been detected in 4% of patients with various gastrointestinal diseases and in 7% of presumably healthy control subjects (2). T. whipplei DNA has also been detected in 40% of subgingival and gingival sulcus samples from healthy individuals (124).…”
mentioning
confidence: 99%
“…We hypothesize that in these cases, the number of T. whipplei bacteria present is very low; thus, DNA is only detected by a more sensitive tool. The PCR specificity for the diagnosis of Whipple's disease has been questioned due to the presence of false-positive results, but study results are discrepant (2,6,7,11,19). Here, T. whipplei DNA was never amplified in our control group despite the fact that we had enhanced the sensitivity of our assay.…”
mentioning
confidence: 75%